-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Abidol Hydrochloride Capsules awarded the title of “China’s Most Innovative Pharmaceutical Formulation.”
Category:
Time：2019-10-29
From October 11 to 13, the 13th China Pharmaceutical Formulation Conference 2019 was grandly held in Yantai, Shandong Province. Concurrent with the conference, two lists were released: the "2019 List of China’s Most Promising Innovative Pharmaceutical Companies" and the "2019 List of China’s Most Innovative Pharmaceutical Formulations." The broad-spectrum antiviral drug Enoda® Abidol capsules, manufactured by our company, was honored as a "2019 Most Innovative Pharmaceutical Formulation."
From October 11 to 13, the 13th China Pharmaceutical Formulation Conference 2019 was grandly held in Yantai, Shandong Province. Concurrent with the conference, two lists were released: the “2019 List of China’s Most Promising and Innovative Pharmaceutical Companies” and the “2019 List of China’s Most Innovative Pharmaceutical Formulations.” The broad-spectrum antiviral drug Aynoda® Abidol capsules, manufactured by our company, was honored as a “2019 Most Innovative Pharmaceutical Formulation.”
This conference is hosted by the Chinese Pharmaceutical Association and jointly organized by the Pharmaceutical Preparations Professional Committee of the Chinese Pharmaceutical Association, the China Chapter of the International Controlled Release Society, and other relevant organizations. It enjoys high authority and influence within the industry. The recognition bestowed upon Enoda® is a well-deserved acknowledgment of the company’s innovative capabilities and R&D excellence. Behind this honor lies the hard work and dedication of the company’s R&D team.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license